Rattus norvegicus
Ontology highlight
ABSTRACT:
PROVIDER: PRJNA87737 | ENA |
REPOSITORIES: ENA
Similar Datasets
Project description:miRNA-99 family diverges physiological cardiac hypertrophy to pathological cardiac hypertrophy
| PRJNA297403 | ENA
Project description:Fibronectin Induced Cardiac Myocyte Hypertrophy
| PRJNA87131 | ENA
Project description:Right ventricular heart failure (RVF) associated with pulmonary hypertension (PH) is characterized by a distinct gene expression pattern when compared with functional compensatory hypertrophy. Carvedilol treatment after RVF has been established reduces right ventricle (RV) hypertrophy and improves the RV function. In addition, carvedilol treatment has been shown to alter the gene expression of select genes. We sought to identify, on a genome-wide basis, the effect of carvedilol on gene expression. RVF was induced in male Sprague-Dawley rats by the combination of VEGF-receptor blockade and chronic hypoxia; thereafter, one group was treated with carvedilol. RNA was isolated from the RV and subjected to microarray analysis. A prediction analysis of the carvedilol-treated RVs showed that carvedilol treated RVs most resembled in their expression pattern the RVF pattern. However, an analysis beyond the boundaries of the prediction set revealed a small set of genes associated with carvedilol reversal of RVF. Pathway analysis of this set of genes revealed expression changes of genes involved in cardiac hypertrophy, mitochondrial dysfunction, protein ubiquitination, and sphingolipid metabolism. Genes encoding proteins in the cardiac hypertrophy and protein ubiquitination pathways were downregulated in the RV by carvedilol, while genes encoding proteins in the mitochondrial dysfunction and sphingolipid metabolism pathways were upregulated by carvedilol.
2013-05-06 | GSE42579 | GEO
Project description:Time course study of experimental cardiac hypertrophy in rat
| PRJNA127139 | ENA
Project description:Methylation of H3K9 by G9a/GLP protects against pathological cardiac hypertrophy
| PRJNA277628 | ENA
Project description:Fetal-Adult Cardiac Transcriptome Analysis in Rats with Contrasting Left Ventricular Mass Reveals New Candidates for Cardiac Hypertrophy
| PRJNA232301 | ENA
Project description:Whole-transcriptome analysis identifies re-expression of fetal splice variants in cardiac hypertrophy
| PRJNA181346 | ENA
Project description:Emodin and emodin-rich rhubarb inhibits histone deacetylase (HDAC) activity and cardiac myocyte hypertrophy Pathological cardiac hypertrophy is a classical hallmark of heart failure. At the molecular level, inhibition of histone deactylase (HDAC) e
| PRJNA602553 | ENA